Tyche Wealth Partners’s AbbVie ABBV Stock Holding History

Tyche Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.38M	Sell	17,400 -1,730	-9%	-$372K	0.61%	36
2026 Q1	$4.16M	Sell	19,130 -317	-2%	-$70.3K	0.64%	35
2025 Q4	$4.44M	Buy	19,447 +2,470	+15%	+$563K	0.71%	31
2025 Q3	$3.93M	Sell	16,977 -2,038	-11%	-$415K	0.69%	31
2025 Q2	$3.53M	Buy	19,015 +390	+2%	+$72.5K	0.71%	33
2025 Q1	$3.9M	Sell	18,625 -3,543	-16%	-$689K	0.84%	26
2024 Q4	$3.94M	Buy	22,168 +4,182	+23%	+$769K	0.83%	27
2024 Q3	$3.55M	Buy	17,986 +34	+0.2%	+$6.35K	0.8%	30
2024 Q2	$3.08M	Buy	17,952 +3,488	+24%	+$578K	0.75%	32
2024 Q1	$2.63M	Buy	14,464 +318	+2%	+$54.8K	0.64%	34
2023 Q4	$2.19M	Buy	+14,146	New	+$2.06M	0.53%	40

Other funds holding ABBV

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Tyche Wealth Partners's ABBV Position: Q2 2026 in Review

Tyche Wealth Partners reduced its AbbVie (ABBV) stake by 9% in Q2 2026, selling an estimated $372K and leaving 17,400 shares worth $4.38M. The position accounts for 0.61% of the portfolio, ranked #36.

Tyche Wealth Partners first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.44M in Q4 2025. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Tyche Wealth Partners held 17,400 shares of AbbVie worth $4.38M as of Q2 2026.
Tyche Wealth Partners sold 1,730 AbbVie shares in Q2 2026, an estimated $372K.
AbbVie made up 0.61% of Tyche Wealth Partners's portfolio in Q2 2026, its #36 holding.
Tyche Wealth Partners first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Tyche Wealth Partners's AbbVie position peaked at $4.44M in Q4 2025.
2,655 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tyche Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.